Bhaskar Bhardwaj1, Joaquin E Cigarroa1, Firas Zahr2. 1. Division of Cardiology, Knight Cardiovascular Institute, OHSU, Portland, OR, United States. 2. Division of Cardiology, Knight Cardiovascular Institute, OHSU, Portland, OR, United States. zahr@ohsu.edu.
Abstract
PURPOSE OF REVIEW: In this review, we have focused on the currently available transcatheter tricuspid valve therapies, device selection, as well as role and management of tricuspid regurgitation (TR) in the setting of other transcatheter valvular procedures. RECENT FINDINGS: In this review, we have enlisted the recently finished as well as ongoing trials in the percutaneous tricuspid valve therapies. TR is highly prevalent yet remains underrecognized and is often untreated. TR has traditionally been managed conservatively with medical therapies including diuretics for volume management, whereas surgical therapies are reserved for those undergoing left-sided valvular surgery. Although the transcatheter devices for tricuspid repair and replacement are in clinical trials, the experience to date for their effectiveness and safety has been reassuring.
PURPOSE OF REVIEW: In this review, we have focused on the currently available transcatheter tricuspid valve therapies, device selection, as well as role and management of tricuspid regurgitation (TR) in the setting of other transcatheter valvular procedures. RECENT FINDINGS: In this review, we have enlisted the recently finished as well as ongoing trials in the percutaneous tricuspid valve therapies. TR is highly prevalent yet remains underrecognized and is often untreated. TR has traditionally been managed conservatively with medical therapies including diuretics for volume management, whereas surgical therapies are reserved for those undergoing left-sided valvular surgery. Although the transcatheter devices for tricuspid repair and replacement are in clinical trials, the experience to date for their effectiveness and safety has been reassuring.
Authors: Rebecca T Hahn; Michael Nabauer; Michel Zuber; Tamim M Nazif; Jörg Hausleiter; Maurizio Taramasso; Alberto Pozzoli; Isaac George; Susheel Kodali; Vinayak Bapat; Francesco Maisano Journal: JACC Cardiovasc Imaging Date: 2019-03
Authors: J P Singh; J C Evans; D Levy; M G Larson; L A Freed; D L Fuller; B Lehman; E J Benjamin Journal: Am J Cardiol Date: 1999-03-15 Impact factor: 2.778
Authors: Yan Topilsky; Simon Maltais; Jose Medina Inojosa; Didem Oguz; Hector Michelena; Joseph Maalouf; Douglas W Mahoney; Maurice Enriquez-Sarano Journal: JACC Cardiovasc Imaging Date: 2018-08-15
Authors: Nelson Wang; Jordan Fulcher; Nishan Abeysuriya; Michele McGrady; Ian Wilcox; David Celermajer; Sean Lal Journal: Eur Heart J Date: 2019-02-01 Impact factor: 29.983
Authors: Chad J Zack; Erin A Fender; Pranav Chandrashekar; Yogesh N V Reddy; Courtney E Bennett; John M Stulak; Virginia M Miller; Rick A Nishimura Journal: J Am Coll Cardiol Date: 2017-12-19 Impact factor: 24.094
Authors: Edgard A Prihadi; Victoria Delgado; Rebecca T Hahn; Jonathon Leipsic; James K Min; Jeroen J Bax Journal: JACC Cardiovasc Imaging Date: 2018-05